A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

BACKGROUND: Platelet activation has been implicated in the pathogenesis of sickle cell disease (SCD) suggesting antiplatelet agents may be therapeutic. To evaluate the safety of prasugrel, a thienopyridine antiplatelet agent, in adult patients with SCD, we conducted a double-blind, randomized, place...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Wun, Ted, Soulieres, Denis, Frelinger, Andrew L, Krishnamurti, Lakshmanan, Novelli, Enrico M, Kutlar, Abdullah, Ataga, Kenneth I, Knupp, Charles L, McMahon, Lillian E, Strouse, John J, Zhou, Chunmei, Heath, Lori E, Nwachuku, Chuke E, Jakubowski, Joseph A, Riesmeyer, Jeffrey S, Winters, Kenneth J
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2013
विषय:
Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3585853/
https://ncbi.nlm.nih.gov/pubmed/23414938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-17
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन